Search
Search
About
Log in
Join
Experiences with
Lung lobectomy
Posts
Communities
2,273 public posts
Filter results
Colon Mass Secondary to Lung Cancer
My father had upper right
lung
lobectomy
in 2017 and finished chemotherapy, now he has a colon mass, his gastro doctor said he needs to undergo chemotherapy first to make the tumor smaller then will proceed to surgery. I am confused. Worried. What if it will grow more...
My father had upper right
lung
lobectomy
in 2017 and finished chemotherapy, now he has a colon mass, his gastro doctor said he needs to undergo chemotherapy first to make the tumor smaller then will proceed to surgery. I am confused. Worried. What if it will grow more...
BonusBook
in
Lung Conditions Community Forum
4 years ago
Southampton scientists make major asbestos cancer breakthrough.
SOUTHAMPTON scientists have made a major breakthrough that could help patients with mesothelioma survive for longer. Mesothelioma is an aggressive form of cancer that is linked to breathing in asbestos fibres. Currently seven per cent of people survive their disease for five years or more. People
SOUTHAMPTON scientists have made a major breakthrough that could help patients with mesothelioma survive for longer. Mesothelioma is an aggressive form of cancer that is linked to breathing in asbestos fibres. Currently seven per cent of people survive their disease for five years or more. People
2greys
in
Lung Conditions Community Forum
3 years ago
Lung Cancer: Comparing Patient-Reported Outcomes in the CROWN Study
The abstract “Patient-reported outcomes from the randomized Phase 3 CROWN study of first-line lorlatinib versus crizotinib in ALK+ NSCLC” by Mazieres et al., presents a welcome analysis of symptoms and health-related quality of life (QOL) in those patients receiving the ALK inhibitors crizotinib vs.
The abstract “Patient-reported outcomes from the randomized Phase 3 CROWN study of first-line lorlatinib versus crizotinib in ALK+ NSCLC” by Mazieres et al., presents a welcome analysis of symptoms and health-related quality of life (QOL) in those patients receiving the ALK inhibitors crizotinib vs.
2greys
in
Lung Conditions Community Forum
3 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Selected Gene mRNA Expression Is Not Predictive of Improved Overall Survival Among Patients Undergoing Surgery for Stage II-III Lung Cancer.
A phase III study examining whether messenger (m)RNA expression correlated with sensitivity or resistance to chemotherapy did not confer a statistically significant advantage in overall survival for patients with resected stage II-III non-small cell lung cancer (NSCLC), according to research presented
A phase III study examining whether messenger (m)RNA expression correlated with sensitivity or resistance to chemotherapy did not confer a statistically significant advantage in overall survival for patients with resected stage II-III non-small cell lung cancer (NSCLC), according to research presented
2greys
in
Lung Conditions Community Forum
3 years ago
Lung Cancer: TALENT Study Supports NLCST and NELSON Trial Results
A study presented today by researchers with the Ministry of Health and Welfare in Taiwan confirmed the effectiveness of low-dose computed tomography (LDCT) screening in a pre-defined, never-smoker, high-risk population. The research was presented today at the International Association for the Study of
A study presented today by researchers with the Ministry of Health and Welfare in Taiwan confirmed the effectiveness of low-dose computed tomography (LDCT) screening in a pre-defined, never-smoker, high-risk population. The research was presented today at the International Association for the Study of
2greys
in
Lung Conditions Community Forum
3 years ago
Lung Cancer: LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate.
Primary analysis of the Lung Cancer Mutation Consortium (LCMC) 3 study revealed that neoadjuvant atezolizumab prior to lung cancer surgery was well tolerated by patients and met its primary endpoint of 20% major pathologic response rate, according to research presented today at the International Association
Primary analysis of the Lung Cancer Mutation Consortium (LCMC) 3 study revealed that neoadjuvant atezolizumab prior to lung cancer surgery was well tolerated by patients and met its primary endpoint of 20% major pathologic response rate, according to research presented today at the International Association
2greys
in
Lung Conditions Community Forum
3 years ago
Nivolumab effective treatment for malignant mesothelioma.
Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer. Malignant mesothelioma is an intractable cancer, and no phase III trial
Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer. Malignant mesothelioma is an intractable cancer, and no phase III trial
2greys
in
Lung Conditions Community Forum
3 years ago
Road Rage!
A piece of road walks into a bar and declares to all its occupants: "I'm the hardest bit of bitumen in the whole of this town!" The piano player stops and the bar goes deadly silent. After a brief pause, all eyes drop, the pianist returns to playing and the piece of road pulls up a bar stool
A piece of road walks into a bar and declares to all its occupants: "I'm the hardest bit of bitumen in the whole of this town!" The piano player stops and the bar goes deadly silent. After a brief pause, all eyes drop, the pianist returns to playing and the piece of road pulls up a bar stool
2greys
in
Lung Conditions Community Forum
3 years ago
Missing protein helps small cell lung cancer evade immune defences.
Small cell lung cancer (SCLC) cells are missing a surface protein that triggers an immune response, allowing them to hide from one of the body’s key cancer defenses, a new study led by UT Southwestern researchers suggests. The findings, reported online today in Cancer Research, a journal of the American
Small cell lung cancer (SCLC) cells are missing a surface protein that triggers an immune response, allowing them to hide from one of the body’s key cancer defenses, a new study led by UT Southwestern researchers suggests. The findings, reported online today in Cancer Research, a journal of the American
2greys
in
Lung Conditions Community Forum
3 years ago
New combination of immunotherapies shows great promise for treating lung cancer.
McMaster researchers have established in lab settings that a novel combination of two forms of immunotherapy can be highly effective for treating lung cancer, which causes more deaths than any other form of cancer. The new treatment, yet to be tested on patients, uses one form of therapy to kill a significant
McMaster researchers have established in lab settings that a novel combination of two forms of immunotherapy can be highly effective for treating lung cancer, which causes more deaths than any other form of cancer. The new treatment, yet to be tested on patients, uses one form of therapy to kill a significant
2greys
in
Lung Conditions Community Forum
3 years ago
Anxious
I’ve just read on another page of a very brave young lady having a right
lung
lobectomy
today and they are also removing 3 ribs?! Im obviously hopeful for curative surgery, but the thought of loosing ribs hadn’t even crossed my mind? Does that happen a lot with lobectomy?
I’ve just read on another page of a very brave young lady having a right
lung
lobectomy
today and they are also removing 3 ribs?! Im obviously hopeful for curative surgery, but the thought of loosing ribs hadn’t even crossed my mind? Does that happen a lot with lobectomy?
Kbucie
in
The Roy Castle Lung Cancer Foundation
4 years ago
Here we go again!
Had 2 thirds of my right lung removed in June (followed by Chemo & Radiotherapy). Latest scan shows that the cancer is back along the "Cut" where the left the top part of my lung. Can't believe its back after only 6 months (and with all the chemo & Radiotherapy). They are saying its inoperable and
Had 2 thirds of my right lung removed in June (followed by Chemo & Radiotherapy). Latest scan shows that the cancer is back along the "Cut" where the left the top part of my lung. Can't believe its back after only 6 months (and with all the chemo & Radiotherapy). They are saying its inoperable and
Ian_cee
in
The Roy Castle Lung Cancer Foundation
3 years ago
Stage 4 central mediastinal mass
After a lobectomy 3 years ago, I now have a stage 4 central mediastinal mass. No reoccurrence in the lung or spread to other organs. I have been told that only palliative treatment is possible and offered (covid permitting) chemotherapy with immunotherapy. Has anyone experience of this cancer?
After a lobectomy 3 years ago, I now have a stage 4 central mediastinal mass. No reoccurrence in the lung or spread to other organs. I have been told that only palliative treatment is possible and offered (covid permitting) chemotherapy with immunotherapy. Has anyone experience of this cancer?
Guys17
in
The Roy Castle Lung Cancer Foundation
4 years ago
Stage 4 central mediastinal mass
After a lobectomy 3 years ago, I now have a stage 4 central mediastinal mass. No reoccurrence in the lung or spread to other organs. I have been told that only palliative treatment is possible and offered (covid permitting) chemotherapy with immunotherapy. Has anyone experience of this cancer?
After a lobectomy 3 years ago, I now have a stage 4 central mediastinal mass. No reoccurrence in the lung or spread to other organs. I have been told that only palliative treatment is possible and offered (covid permitting) chemotherapy with immunotherapy. Has anyone experience of this cancer?
Guys17
in
Lung Cancer Support
4 years ago
Stage 4 central mediastinal mass
After a lobectomy 3 years ago, I now have a stage 4 central mediastinal mass. No reoccurrence in the lung or spread to other organs. I have been told that only palliative treatment is possible and offered (covid permitting) chemotherapy with immunotherapy. Has anyone experience of this cancer?
After a lobectomy 3 years ago, I now have a stage 4 central mediastinal mass. No reoccurrence in the lung or spread to other organs. I have been told that only palliative treatment is possible and offered (covid permitting) chemotherapy with immunotherapy. Has anyone experience of this cancer?
Guys17
in
Lung Conditions Community Forum
4 years ago
Has anyone received the Covid-19 Vaccine while taking Immunotherapy?
Fellow cancer patients, I have been very concerned about how my immunotherapy (Opdivo/nivolumab) might affect my body’s response to the Covid-19 vaccine. During my past year on this treatment, my immune system has “overresponded” on several occasions as can be a side-effect of the treatment. Although
Fellow cancer patients, I have been very concerned about how my immunotherapy (Opdivo/nivolumab) might affect my body’s response to the Covid-19 vaccine. During my past year on this treatment, my immune system has “overresponded” on several occasions as can be a side-effect of the treatment. Although
Jenniferroseolson
in
Lung Cancer Support
3 years ago
I keep hope alive
I was diagnosed as lung adenocarcinoma stage 4 with EGFR in september 2020 and keep on taking erlotinib. I am ok so far. Thanks god.
I was diagnosed as lung adenocarcinoma stage 4 with EGFR in september 2020 and keep on taking erlotinib. I am ok so far. Thanks god.
gatonegro
in
The Roy Castle Lung Cancer Foundation
3 years ago
Would you like to have a friendly chat with a UCL researcher about your experiences of being diagnosed with lung cancer?
[i][Happy New Year everyone. We're still recruiting to this study in case there are any new members or people who still wanted to take part] [/i] Were you diagnosed with lung cancer within the last 12 months? Have your say about your experiences in the PEARL study - a research programme led by UCL and
[i][Happy New Year everyone. We're still recruiting to this study in case there are any new members or people who still wanted to take part] [/i] Were you diagnosed with lung cancer within the last 12 months? Have your say about your experiences in the PEARL study - a research programme led by UCL and
georgiabellblack
in
The Roy Castle Lung Cancer Foundation
4 years ago
Cavitating lung lesion - shadow/mass
3.7cm cavitating lung lesion mid lung, this is what is written on my husbands notes after he had a chest X-ray for something else last week, he has no symptoms of a chest problem but he is a smoker whose dad died of lung cancer, he now thinks he’s about to die too as he’s constantly on DR Google. Please
3.7cm cavitating lung lesion mid lung, this is what is written on my husbands notes after he had a chest X-ray for something else last week, he has no symptoms of a chest problem but he is a smoker whose dad died of lung cancer, he now thinks he’s about to die too as he’s constantly on DR Google. Please
Lolorose
in
Lung Conditions Community Forum
4 years ago
Good news - Stage IIIB
Hi all, just wanted to share good news. I have had clear scan results today after being diagnosed with Stage IIIB, non small cell, adenocarcinoma in 2014, aged 43. My prognosis at the time was poor and I was told I was inoperable, terminal and treatable with palliative care. Discussions were around
Hi all, just wanted to share good news. I have had clear scan results today after being diagnosed with Stage IIIB, non small cell, adenocarcinoma in 2014, aged 43. My prognosis at the time was poor and I was told I was inoperable, terminal and treatable with palliative care. Discussions were around
Janey_H
in
Lung Cancer Support
4 years ago
1
...
25
26
27
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Lung Conditions Community Forum
846 results
The Roy Castle Lung Cancer Foundation
668 results
Lung Cancer Support
463 results
View top 10 communities
Sort by
Most Relevant
Newest